Health Strategies

Dáil Éireann Debate, Tuesday - 5 November 2024

• Díospóireachtaí
• Aimsigh díospóireacht
  • Díospóireachtaí na Dála
  • Díospóireachtaí an tSeanaid
  • Díospóireachtaí Coiste
• Aimsigh vótáil
  • Vótálacha na Dála
  • Vótálacha an tSeanaid
  • Vótálacha Coiste
• Ceisteanna Parlaiminte
  • Ceisteanna scríofa
  • Ceisteanna ó bhéal
• Leideanna cuardaigh
• Nuair a bhíonn tionchar tromchúiseach ag aithrisí

Tuesday, 5 November 2024

Ceisteanna (1103)

Richard Bruton

Ceist:

1103. Deputy Richard Bruton asked the Minister for Health how his Department and the HSE plans to widen access to continuous glucose monitoring technology for people with Type 1 diabetes to improve their diabetes management and quality of life; and if he will make a statement on the matter. [44292/24]

Freagraí scríofa

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medical products; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• An Freagra Roimhe Sin
• An Chéad Fhreagra eile